Cargando…

Cholinesterase inhibitors from botanicals

Alzheimer's disease (AD) is a progressive neurodegenerative disease, wherein a progressive loss of cholinergic synapses occurs in hippocampus and neocortex. Decreased concentration of the neurotransmitter, acetylcholine (ACh), appears to be critical element in the development of dementia, and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Faiyaz, Ghalib, Raza Murad, Sasikala, P., Ahmed, K. K. Mueen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841990/ https://www.ncbi.nlm.nih.gov/pubmed/24347920 http://dx.doi.org/10.4103/0973-7847.120511

Ejemplares similares

Cholinesterase inhibitors as Alzheimer's therapeutics
por: Sharma, Kamlesh
Publicado: (2019)

Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl- and Thioxo-1,2,4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors
por: Raza, Ahsan, et al.
Publicado: (2012)

Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors
por: George, Ginson, et al.
Publicado: (2022)

Proline-Based Carbamates as Cholinesterase Inhibitors †
por: Pizova, Hana, et al.
Publicado: (2017)

Honeys as Possible Sources of Cholinesterase Inhibitors
por: Szwajgier, Dominik, et al.
Publicado: (2022)

Evidence-Based Management of Uterine Fibroids With Botanical Drugs-A Review
por: Arip, Masita, et al.
Publicado: (2022)

Environmental Risks of Insecticides Cholinesterase Inhibitors
por: Mandour, Raafat A.
Publicado: (2013)

Natural Inhibitors of Cholinesterases: Chemistry, Structure–Activity and Methods of Their Analysis
por: Smyrska-Wieleba, Natalia, et al.
Publicado: (2023)

Prognostic Factors in Cholinesterase Inhibitor Poisoning
por: Sun, In O, et al.
Publicado: (2015)

Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease
por: Parsons, Chris G., et al.
Publicado: (2013)

Structure-Based Search for New Inhibitors of Cholinesterases
por: Bajda, Marek, et al.
Publicado: (2013)

Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
por: Przybyłowska, Maja, et al.
Publicado: (2021)

Plant Terpenoids as the Promising Source of Cholinesterase Inhibitors for Anti-AD Therapy
por: Lai Shi Min, Shereen, et al.
Publicado: (2022)

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
por: Hu, Ziheng, et al.
Publicado: (2018)

Cholinesterase Inhibitors: Drugs Looking for a Disease?
por: Maggini, Marina, et al.
Publicado: (2006)

The Botanical Atlas
Publicado: (1883)

The Botanical Atlas
Publicado: (1883)

Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors
por: Green, Keith D., et al.
Publicado: (2018)

Cholinesterase Inhibitors from an Endophytic Fungus Aspergillus niveus Fv-er401: Metabolomics, Isolation and Molecular Docking
por: Hamed, Ahmed A., et al.
Publicado: (2023)

Discovery of Natural Inhibitors of Cholinesterases from Hydrangea: In Vitro and In Silico Approaches
por: Hwang, Jayeong, et al.
Publicado: (2021)

Evaluation of Mollugo oppositifolia Linn. as cholinesterase and β-secretase enzymes inhibitor
por: Das, Bhaskar, et al.
Publicado: (2023)

Response to cholinesterase inhibitors affects lifespan in Alzheimer’s disease
por: Wattmo, Carina, et al.
Publicado: (2014)

Combined Hemoperfusion and Hemodialysis Treatment of Poisoning with Cholinesterase Inhibitors
por: Durakovic, Zijad
Publicado: (1993)

Comparison of cholinesterase inhibitor safety in real-world practice
por: Carney, Greg, et al.
Publicado: (2019)

A case report of cholinesterase inhibitor poisoning: cholinesterase activities and analytical methods for diagnosis and clinical decision making
por: Amend, N., et al.
Publicado: (2020)

Memantine combined with an acetyl cholinesterase inhibitor – hope for the future?
por: Fox, Chris, et al.
Publicado: (2006)

Potential revival of cholinesterase inhibitors as drugs in veterinary medicine
por: Žnidaršič, Neža, et al.
Publicado: (2023)

Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story
por: Lam, Benjamin, et al.
Publicado: (2009)

Neuroprotective Effects of Cholinesterase Inhibitors: Current Scenario in Therapies for Alzheimer’s Disease and Future Perspectives
por: Moreira, Natália Chermont dos Santos, et al.
Publicado: (2022)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer’s disease cohort
por: Wattmo, Carina, et al.
Publicado: (2012)

Odor identification impairment and cholinesterase inhibitor treatment in Alzheimer's disease
por: Motter, Jeffrey N., et al.
Publicado: (2021)

Bioactivity-Guided Identification of Botanical Inhibitors of Ketohexokinase
por: Le, MyPhuong T., et al.
Publicado: (2016)

Cholinesterase Research
por: Korabecny, Jan, et al.
Publicado: (2021)

Dietary and botanical anxiolytics
por: Alramadhan, Elham, et al.
Publicado: (2012)

Cholinesterase Enzymes Inhibitors from the Leaves of Rauvolfia Reflexa and Their Molecular Docking Study
por: Fadaeinasab, Mehran, et al.
Publicado: (2013)

New Carrier Made from Glass Nanofibres for the Colorimetric Biosensor of Cholinesterase Inhibitors
por: Matějovský, Lukáš, et al.
Publicado: (2018)

Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer’s Disease
por: Hussein, Weiam, et al.
Publicado: (2018)

Synthesis and Hybrid SAR Property Modeling of Novel Cholinesterase Inhibitors †
por: Kos, Jiri, et al.
Publicado: (2021)

Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
por: Xu, Hong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_75j4fv97vn6oj8357klktvou40